HSPA5 and breast cancer: Interestingly, inhibiting GRP78 resulted in a more M2-like phenotype (Figure 2A and 2D), with decreased macrophage proliferation (Figure 2B), and a decreased macrophage-mediated breast cancer cell killing (Figure 2C).